Abstract
BackgroundSome maternal systemic connective tissue diseases (CTD) and their associated antibodies are linked with adverse fetal outcomes, including increased risk of congenital heart diseases (CHD)[1,2]. Whether this increased risk also...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
